top of page
ATA Posters & Audio
Incidence and Costs of Adverse Events Following Initiation of Pharmacologic Treatment Used to Manage Graves’ Disease: A Real-World Analysis
Lesley-Ann Miller-Wilson,¹ Nicole Princic,² Kristin Evans,² Kylle Tollefsen,¹ David Toro-Tobon³
¹Immunovant, Inc., New York, NY, USA; ²Merative, Ann Arbor, MI, USA; ³Mayo Clinic, Rochester, MN, USA
Incidence and Costs of Adverse Events Following Initiation of Pharmacologic Treatment Used to Manage Graves’ Disease: A Real-World AnalysisLesley-Ann Miller-Wilson,¹ Nicole Princic,² Kristin Evans,² Kylle Tollefsen,¹ David Toro-Tobon³
00:00 / 04:49
bottom of page